New Business Opportunities in Bio/Pharma,
Medical Devices & Diagnostics
| November 2015 |
Welcome to the November 2015 issue of PharmSource PERISCOPE
This monthly e-newsletter provides valuable insight to sales and marketing professionals who sell goods and services to bio/pharma, medical device or diagnostic companies. It helps you recognize new business opportunities and overcome sales obstacles.
Enjoy the November issue!
PharmSource Lead Sheet Global Activity Report:
| Lead Type | October 2015 | 2015 YTD |
|---|---|---|
| Early Development | 79 | 1105 |
| Late Development | 96 | 1032 |
| Biologic | 76 | 892 |
| Small Molecule | 193 | 2269 |
| Parenteral | 80 | 1001 |
| Oral | 81 | 927 |
| New Financings | 84 | 939 |
| Total Drug Leads | 367 | 3856 |
| Total Device & Diagnostic Leads |
160 | 1385 |
*Total leads include acquisitions/alliances, company acquisition/alliances and events.
Early Phase Chemical API Product Development Opportunities
This is a snapshot of new business opportunities likely to surface soon in specific companies with small molecule API drug candidates that are currently in the earliest phases of clinical development. It also points to opportunities arising from newly funded early stage drug companies whose focus is on chemical APIs, but don’t yet have products.
The PharmSource Lead Sheet reports changes in clinical progress of these (and other) candidates: we know when they enter Discovery, when they plan to initiate a next-phase trial, when they report positive results, etc.
The chart below shows the number of these opportunities reported since June 1, 2015. We also know exactly who these companies are, where they’re located, their principal employees, and details on the source and amount of new funding, when applicable-and often more.
Companies with New Financing and
Early Phase Chemical API Drug Products: 6/1/2015 to 11/16/2015
| Status | Total |
|---|---|
| Early Phase Small Molecule Products | 260 |
| Newly financed company but no products yet | 38 |
| TOTAL | 298 |
Source: PharmSource Lead Sheet
It’s strategic to look at Phase 1 opportunities in this category because these companies may be looking for a contract manufacturer that can scale… read on
Pipeline Tip
PhaseBio Pharmaceuticals initiates a Phase IIa study with PE0139 for the treatment of type 2 diabetes:
- Therapeutic Area: Diabetes
- Dosage Form: Parenteral – Liquid
- API: Biologic – Protein – Recombinant
Hormone
Follow the Money: MabVax Therapeutics, Inc.
MabVax Therapeutics, Inc. is a U.S. public pharmaceutical company that develops human antibody-based anti-cancer drugs and cancer diagnostic products. MabVax Therapeutics raised $2.75 million in the completion of a secondary public offering.
What new business opportunities are most likely to surface from this? We know they plan to use the proceeds for working capital and general purposes, as well as for product development, including… read on
User Tip
The CRM/Custom Export feature of the PharmSource Lead Sheet lets you automate a customized recurring weekly Excel CSV export file based on weekly Lead Sheet data.
You can use this feature to set up an automated data feed that meets your specs and can readily be imported into your CRM. When the weekly Lead Sheet is published, you’ll be sent an e-mail with your customized weekly Excel file attached (.csv format) and ready for CRM import and other internal uses. You also can make one-time custom downloads.
The CRM/Custom Export feature greatly streamlines the process of importing data into your CRM, giving you the convenience of only having to set parameters once. To access this, just click on the CRM/Custom Export button in the left nav bar of your weekly Lead Sheet.
If you have any questions, please contact our Director of Account Management, Blythe Moore.
From Your Input to Our Output
by Nathaniel Celentano, Business Development Manager
As you may have noticed, we’re very interested in hearing feedback from our PharmSource Lead Sheet clients. After all, we’ve been offering glorious Starbucks gift cards in return for completed surveys for a few years now (thank you to all our caffeinated responders!).
Getting your feedback is of utmost importance to us, and our entire team looks forward to hearing your comments and suggestions. When it comes to the continued evolution and advancement of our Lead Sheet service, your opinion matters most. We want to know… read on
PharmSource Lead Sheet
The PharmSource Lead Sheet is the industry’s definitive source for identifying targeted new business opportunities in bio/pharmaceutical companies around the world. Our dedicated research team knows how and where to find fresh, targeted leads, and we have the contact information you need to start the sales process.
Don’t be the last to learn about the latest business development opportunities. If you’re not already using the Lead Sheet, contact us today to schedule a complimentary test-drive.
See for yourself how this resource can be a vital tool for building your brand and growing your market share.
To request a test-drive today, contact Nathaniel Celentano at nathaniel@pharmsouce.com / 1-703-383-4903, ext. 112 (ET USA).